查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1493260

美国体外心臟去颤器市场规模、份额和趋势分析报告：按产品、最终用途、细分市场预测，2024-2030 年

U.S. External Defibrillators Market Size, Share & Trends Analysis Report By Product (Manual, Automated, Wearable), By End-use (Hospital, Prehospital, Public Access Market), And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 70 Pages | 商品交期: 2-10个工作天内

价格

美国体外心臟去颤器市场成长与趋势：

Grand View Research最新报告显示，到2030年，美国体外心臟去颤器市场规模预计将达到23.3亿美元，2024年至2030年复合年增长率为9.0%。

心血管疾病发生率的增加是市场成长的主要驱动力。根据美国美国约有 805,000 人心臟病发作。技术进步促进了创新体外心臟去颤器的发展。此外，美国不断上涨的医疗保健成本以及对紧急医疗服务和医疗保健基础设施的投资正在推动医院、诊所、救护车和其他医疗保健设施中产品的采用。

对医疗保健设施投资的增加正在推动对去心房颤动技术的需求。关于心臟麻痹和早期去心房颤动重要性的公众意识提升宣传活动，以及有效使用自动体外心臟心臟去颤器(AED) 的培训计划，在推动市场成长方面发挥关键作用。认识的提高增加了公共设施和私人组织对心臟去颤器的需求。主要企业正在采取各种策略，例如新产品发布、併购和联盟，以获取更高的市场占有率。例如，2023 年 3 月，Safe Life 收购了 Coro Medical 和 AED.us。此次收购将 Safe Life 的救生设备和服务扩展到美国各地。

美国体外心臟去颤器市场报告亮点

  • AED产品细分市场将在2023年占据市场主导地位，占整体收益的40%。预计 2024 年至 2030 年该细分市场将以最快的复合年增长率成长。
  • 这是由于心臟去颤器的技术进步、心血管疾病 (CVD) 盛行率的增加以及人们对即时心臟护理重要性的认识的提高。
  • 由于心臟病导致的住院率上升以及心臟去颤器安装量的增加，医院最终用途部门在 2023 年占据最大收益占有率，超过 25%。
  • 由于人们对早期去心房颤动重要性的认识不断提高并开展了培训计划，预计从 2024 年到 2030 年，公共接入终端使用领域的复合年增长率将达到最快。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章美国体外心臟去颤器市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场推动要素分析
    • 市场限制因素分析
  • 美国体外心臟去颤器市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章美国体外心臟去颤器市场：产品预估及趋势分析

  • 2023年及2030年产品市场占有率
  • 细分仪表板
  • 美国体外心臟去颤器市场：按产品分類的前景
  • 2018-2030年市场规模、预测及趋势分析
  • 手动的
  • 自动的
  • 穿戴式自动心臟去颤器

第五章美国体外心臟去颤器市场：最终用途估计与趋势分析

  • 2023 年及 2030 年最终用途市场占有率
  • 细分仪表板
  • 以最终用途分類的美国体外电击器市场前景
  • 2018-2030年市场规模、预测及趋势分析
  • 医院
  • 院前救护
  • 公共访问
  • 替代性照料
  • 家庭保健

第六章 竞争状况

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
  • 供应商情况
  • 公司简介
    • Koninklijke Philips NV
    • ZOLL Medical Corporation
    • Stryker
    • Nihon Kohden Corporation
    • Shenzhen Mindray Bio-Medical Electronics
    • Schiller Americas, inc.
    • Medtronic
    • Amiitalia
    • MEDIANA Co., Ltd.
Product Code: GVR-4-68040-267-1

U.S. External Defibrillators Market Growth & Trends:

The U.S. external defibrillators market size is anticipated to reach USD 2.33 billion by 2030, registering a CAGR of 9.0% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing incidence of cardiovascular conditions is a major factor contributing to market growth. As per the Centers for Disease Control and Prevention (CDC), every year in the U.S., around 805,000 people have a heart attack. Technological advancements have led to the development of innovative external defibrillators. In addition, the growing healthcare expenditure in the U.S., coupled with investments in emergency medical services and healthcare infrastructure, has supported the product adoption in hospitals, clinics, ambulances, and other healthcare facilities.

This increased investment in healthcare facilities has boosted the demand for advanced defibrillation technologies. Public awareness campaigns about sudden cardiac arrest & the importance of early defibrillation, along with training programs on using automated external defibrillators (AEDs) effectively, have played a crucial role in driving market growth. Increased awareness has led to a higher demand for defibrillators in public settings and private organizations. Key companies undertake various strategies, such as new product launches, M&As, and partnerships, to gain higher market shares. For instance, in March 2023, Safe Life acquired Coro Medical and AED.us. This acquisition helped expand Safe Life's life-saving equipment and services across the U.S.

U.S. External Defibrillators Market Report Highlights:

  • The AED product segment dominated the market in 2023 and around for a share of 40% of the overall revenue. The segment is expected to grow at the fastest CAGR from 2024 to 2030
  • This can be attributed to the technological advancements in defibrillator devices, increasing prevalence of cardiovascular diseases (CVDs), and growing awareness about the importance of immediate cardiac care
  • The hospital end-use segment accounted for the largest revenue share of over 25% in 2023 owing to increased rates of hospital admissions due to heart conditions and increasing defibrillator installations
  • The public access end-use segment is anticipated to witness the fastest CAGR from 2024 to 2030 due to the rising awareness of the importance of early defibrillation and training programs

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. End-use
    • 1.2.3. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Volume price analysis (Model 2)
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. End-use outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. External Defibrillators Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing incidences of cardiac arrest
      • 3.2.1.2. Technological advancements
      • 3.2.1.3. Increasing healthcare expenditure
      • 3.2.1.4. Growing awareness and training program
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Stringent regulations & approvals
      • 3.2.2.2. Limited accessibility
  • 3.3. U.S. External Defibrillators Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. U.S. External Defibrillators Market: Product Estimates & Trend Analysis

  • 4.1. Product Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. U.S. External Defibrillators Market by Product Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 For The Following
    • 4.4.1. Manual
      • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Automated
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Wearable Cardioverter Defibrillators
      • 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. U.S. External Defibrillators Market: End-use Estimates & Trend Analysis

  • 5.1. End-use Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. U.S. External Defibrillators Market by End-use Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
    • 5.4.1. Hospital
      • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Prehospital
      • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. Public Access Market
      • 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.4. Alternate Care Market
      • 5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.5. Home Healthcare
      • 5.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Company/Competition Categorization
  • 6.3. Vendor Landscape
    • 6.3.1. List of key distributors and channel partners
    • 6.3.2. Key customers
    • 6.3.3. Key company heat map analysis, 2023
  • 6.4. Company Profiles
    • 6.4.1. Koninklijke Philips N.V.
      • 6.4.1.1. Company overview
      • 6.4.1.2. Financial performance
      • 6.4.1.3. Product benchmarking
      • 6.4.1.4. Strategic initiatives
    • 6.4.2. ZOLL Medical Corporation
      • 6.4.2.1. Company overview
      • 6.4.2.2. Financial performance
      • 6.4.2.3. Product benchmarking
      • 6.4.2.4. Strategic initiatives
    • 6.4.3. Stryker
      • 6.4.3.1. Company overview
      • 6.4.3.2. Financial performance
      • 6.4.3.3. Product benchmarking
      • 6.4.3.4. Strategic initiatives
    • 6.4.4. Nihon Kohden Corporation
      • 6.4.4.1. Company overview
      • 6.4.4.2. Financial performance
      • 6.4.4.3. Product benchmarking
      • 6.4.4.4. Strategic initiatives
    • 6.4.5. Shenzhen Mindray Bio-Medical Electronics
      • 6.4.5.1. Company overview
      • 6.4.5.2. Financial performance
      • 6.4.5.3. Product benchmarking
      • 6.4.5.4. Strategic initiatives
    • 6.4.6. Schiller Americas, inc.
      • 6.4.6.1. Company overview
      • 6.4.6.2. Financial performance
      • 6.4.6.3. Product benchmarking
      • 6.4.6.4. Strategic initiatives
    • 6.4.7. Medtronic
      • 6.4.7.1. Company overview
      • 6.4.7.2. Financial performance
      • 6.4.7.3. Product benchmarking
      • 6.4.7.4. Strategic initiatives
    • 6.4.8. Amiitalia
      • 6.4.8.1. Company overview
      • 6.4.8.2. Financial performance
      • 6.4.8.3. Product benchmarking
      • 6.4.8.4. Strategic initiatives
    • 6.4.9. MEDIANA Co., Ltd.
      • 6.4.9.1. Company overview
      • 6.4.9.2. Financial performance
      • 6.4.9.3. Product benchmarking
      • 6.4.9.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 U.S. external defibrillators market, by product, 2018 - 2030 (USD Million)
  • Table 3 U.S. external defibrillators market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 U.S. external defibrillators market: market outlook
  • Fig. 9 U.S. external defibrillators competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 U.S. external defibrillators market driver impact
  • Fig. 14 U.S. external defibrillators market restraint impact
  • Fig. 15 U.S. external defibrillators market: Product movement analysis
  • Fig. 16 U.S. external defibrillators market: Product outlook and key takeaways
  • Fig. 17 Manual market estimates and forecast, 2018 - 2030
  • Fig. 18 Automated market estimates and forecast, 2018 - 2030
  • Fig. 19 Wearable cardioverter defibrillators market estimates and forecast, 2018 - 2030
  • Fig. 20 U.S. external defibrillators Market: End-use movement Analysis
  • Fig. 21 U.S. external defibrillators market: End-use outlook and key takeaways
  • Fig. 22 Hospital market estimates and forecasts, 2018 - 2030
  • Fig. 23 Pre-hospital market estimates and forecasts, 2018 - 2030
  • Fig. 24 Public access market estimates and forecasts, 2018 - 2030
  • Fig. 25 Alternate care market estimates and forecasts, 2018 - 2030
  • Fig. 26 Home healthcare market estimates and forecasts, 2018 - 2030